Printer friendly

What does NRDL stand for?

NRDL stands for National Reimbursement Drug List (China)

This definition appears very rarely and is found in the following Acronym Finder categories:

  • Military and Government
  • Science, medicine, engineering, etc.
  • Organizations, NGOs, schools, universities, etc.

See other definitions of NRDL

Other Resources:
We have 1 other meaning of NRDL in our Acronym Attic

Samples in periodicals archive:

Decision Resources' new Emerging Markets Physician & Payer Forum report entitled Oral Therapies for Type 2 Diabetes - Physician and Payer Perspectives on the Dynamics in the Chinese and South Korean Markets explores the implications of the fact that DPP-IV inhibitors do not currently appear on China's National Reimbursement Drug List (last updated in 2009, prior to the launch of any drug from this class) and therefore experience very low uptake.
Trends -Domestic Chinese Pharmaceutical Companies -- Overview -- Domestic Pharmaceutical Companies' Changing Strategies - Pharmaceutical Distribution in China - Predicted Trends -- Overview -- Healthcare Providers -- Healthcare Funding -- Reimbursement System -- Price Determination -- Regulatory Approvals - Conclusion Appendix A: Recent Acquisitions, Ventures, and Partnerships in the Chinese Drug Industry Appendix B: National Reimbursement Drug List Companies Mentioned: AstraZeneca, Pfizer, Bayer Schering, Roche, Sanofi Aventis, Novartis, GSK, Merck, Novo Nordisk, Eli Lilly, Nycomed, Yangzijiang Pharma, Guangzhou Banyunshan Pharma, North China Pharmaceutical Co.